Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Antiva Biosciences, Inc.

Antiva Biosciences, Inc.

Stage unknownRedwood City, CABiotechnology
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
1 rounds
  1. Apr 24, 2023
    Form D equity offering · $38.5M (form d sold) · 21 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Antiva Biosciences, Inc. filed Form D/A: $38,535,985 sold of $52,999,990, Biotechnology”
Investors on record
1 edges
People
4 officers, 6 directors
Timeline
1
  1. Oct 11, 2024
    Antiva Biosciences, Inc. filed Form D/A: $38,535,985 sold of $52,999,990, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
16 observations
Every observation on this company